Skip to main content

Home/ INVESTING IN THE STOCK MARKET/ Group items tagged Lupus sufferers

Rss Feed Group items tagged

Equities Group

Can Human Genome's Lupus Drug Help them Become Profitable?? | equities.com - 0 views

  •  
    As the first new Lupus drug to debut in the last half-of-a-century, Benlysta has the potential to be something special. Reception of the drug from doctors has been lukewarm thus far, but with many other treatments associated with severe potential side effects, Benlysta may be a blockbuster nonetheless.
1 - 1 of 1
Showing 20 items per page